SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042434
Filing Date
2023-08-14
Accepted
2023-08-14 16:18:22
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cfrx-20230630.htm   iXBRL 10-Q 2725178
2 EX-31.1 cfrx-ex31_1.htm EX-31.1 16392
3 EX-31.2 cfrx-ex31_2.htm EX-31.2 16130
4 EX-32.1 cfrx-ex32_1.htm EX-32.1 23253
  Complete submission text file 0000950170-23-042434.txt   9352723

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cfrx-20230630_def.xml EX-101.DEF 180834
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cfrx-20230630_cal.xml EX-101.CAL 39056
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cfrx-20230630.xsd EX-101.SCH 51642
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cfrx-20230630_lab.xml EX-101.LAB 414197
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cfrx-20230630_pre.xml EX-101.PRE 323498
62 EXTRACTED XBRL INSTANCE DOCUMENT cfrx-20230630_htm.xml XML 1737368
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 231170522
SIC: 2834 Pharmaceutical Preparations